Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. [electronic resource]
Producer: 20140311Description: E359-67 p. digitalISSN:- 1399-0012
- Adult
- Case-Control Studies
- Cyclosporine -- therapeutic use
- Delayed Graft Function
- Drug Therapy, Combination
- Dyslipidemias -- diagnosis
- Everolimus
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
- Graft Rejection -- diagnosis
- Graft Survival
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kidney Failure, Chronic -- complications
- Kidney Function Tests
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Mycophenolic Acid -- analogs & derivatives
- Postoperative Complications
- Prognosis
- Prospective Studies
- Risk Factors
- Sirolimus -- analogs & derivatives
- Survival Rate
- Tacrolimus -- therapeutic use
- Tissue Donors
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.